Firm
The firm reported a small uptick in overall revenue and profit per equity partner, while its IP team secured notable life sciences victories
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
Sponsored
Sponsored
-
Sponsored by Spoor & FisherPaul Ramara from Spoor & Fisher explains the importance of relationship-building for brand owners dealing with enforcement authorities and customs officials -
Sponsored by Patrinos & KilimirisEvangelia Sioumala of Patrinos & Kilimiris looks at a recent judgment from the Athens Administrative Court of First Instance that favours the verbal elements of a trademark
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law looks at how the Korean Intellectual Property Office (KIPO) and the Korean courts have judged the registrability and validity of pharmaceutical trademarks according to more specific criteria
-
Sponsored by Gün and PartnersUğur Aktekin and Zeynep Seda Alhas of Gün and Partners explore how the disruption caused by the coronavirus pandemic affected the enforcement of trademark rights in Turkey
-
Sponsored by AJ ParkAJ Park discusses the impact of the RCEP agreement on geographical indications and Māori traditional knowledge in New Zealand
-
Sponsored by GoldenGate LawyersBruce Fu of GoldenGate Lawyers explains the key changes that will streamline the registration procedure and better protect the interests of enterprises
